Core Viewpoint - The Beijing Chaoyang District Court has sentenced four employees of Tongrentang for illegally producing and selling An Gong Niu Huang Wan, emphasizing the importance of maintaining the reputation of traditional Chinese medicine brands and ensuring public health safety [1][2]. Group 1: Case Details - The defendants, Wang, Sui, Wang, and Qiu, were employees of Beijing Tongrentang Pharmaceutical Factory and illegally produced An Gong Niu Huang Wan from 2020 to July 2023, generating sales exceeding 800,000 RMB [1][2]. - The court found that the defendants violated drug management regulations by producing and selling drugs without the necessary approvals, which posed a serious risk to public health [2]. Group 2: Legal Implications - The court ruled that the actions of the defendants constituted a crime of obstructing drug management, with sentences ranging from one year and six months to three years and six months, along with fines between 100,000 RMB and 600,000 RMB [2]. - The case highlights the severe consequences of unauthorized drug production, particularly for emergency medications intended for vulnerable populations such as pregnant women and critically ill patients [2]. Group 3: Industry Impact - The ruling serves to protect public health and create a fair market environment for traditional Chinese medicine brands, reinforcing the value and reputation of time-honored enterprises like Tongrentang [2].
维护老字号品牌声誉 4名非法生产、销售安宫牛黄丸的同仁堂“内鬼”均获刑